Financial report interval: 2025.12.31 - 2026.03.31
Preview: Biofrontera(BFRI) predict that the Revenue is 10.08 M (+17.42%), Miss estimate;the EBIT is -4.32 M (+4.99%), Miss estimate;the EPS is -0.41 (+12.77%), Miss estimate.